TargED Biopharmaceuticals

TargED Biopharmaceuticals B.V. is a Netherlands based biotechnology company that develops first-in-class biological drugs to improve treatment of thrombosis. TargED’s unique biological drugs use small antibodies (‘VHH’) to deliver enzymes to sites of thrombosis, enabling ‘targeted’ thrombolysis.